Insider Transactions Reported by 25 Insiders of BiomX Inc.

Symbol
PHGE on NYSE
Location
Dover, DE

Insiders trading volume in the past year

BiomX Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
OrbiMed Israel BioFund GP Limited Partnership 10%+ Owner $5,250,517 15 May 2024
James E. Flynn Director, *Director by Deputization $2,321,016 21 Apr 2025
Cystic Fibrosis Foundation 10%+ Owner $1,663,688 26 Feb 2025
Chidozie Ugwumba Exit Form 4 - former 10% owner $1,018,989 17 Oct 2022
Jonathan Eitan Solomon Chief Executive Officer, Director $72,246 14 Apr 2025
Merav Bassan Chief Development Officer $45,370 14 Apr 2025
Marina Wolfson Chief Financial Officer $39,070 14 Apr 2025
Assaf Oron Chief Business Officer $9,836 16 Sep 2024
Paul J. Sekhri Director $4,250 28 Jul 2021
Reuven Yeganeh Director, 10%+ Owner $0 -$8,250,000 -100% 16 Mar 2026
Gbolahan Amusa Director 29 Mar 2022
Thomas Layton Walton 10%+ Owner 31 Dec 2021
Dambach Michael E. Director 21 Aug 2023
Jonas Grossman Director 29 Mar 2022
Susan Blum Director 14 Apr 2025
Liat Cohavi Bidas Director 13 Feb 2026
Gregory Louis Merril Director 14 Apr 2025
Marks Jason M. Director 21 Aug 2023
Avraham Gabay Interim CFO 06 Dec 2023
Russell Greig Director 14 Apr 2025
Jesse Goodman Director 14 Apr 2025
Jonathan S. Leff Director 14 Apr 2025
Eddie Williams Director 14 Apr 2025
Lynne Marie Sullivan Director 01 Mar 2023
Alan Charles Moses Director 14 Apr 2025

Recent Insider Transactions by Companies or Individuals for BiomX Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Reuven Yeganeh PHGE Common Stock, $0.0001 par value per share Sale -100% $2,650,000 $5.00 -530,000 0 17 Mar 2026 Pyu Pyu Capital LLC
Reuven Yeganeh PHGE Common Stock, $0.0001 par value per share Conversion of derivative security 530,000 530,000 17 Mar 2026 Pyu Pyu Capital LLC
Reuven Yeganeh PHGE Series Y Convertible Preferred Stock Conversion of derivative security -100% -1,060 0 17 Mar 2026 Pyu Pyu Capital LLC
Reuven Yeganeh PHGE Common Stock, $0.0001 par value per share Sale -100% $2,250,000 $5.00 -450,000 0 16 Mar 2026 Pyu Pyu Capital LLC
Reuven Yeganeh PHGE Common Stock, $0.0001 par value per share Conversion of derivative security 450,000 450,000 16 Mar 2026 Pyu Pyu Capital LLC
Reuven Yeganeh PHGE Common Stock Purchase Warrants Sale -100% -5,000,000 0 16 Mar 2026 Pyu Pyu Capital LLC
Reuven Yeganeh PHGE Series Y Convertible Preferred Stock Conversion of derivative security -45.9% -900 1,060 16 Mar 2026 Pyu Pyu Capital LLC
Reuven Yeganeh PHGE Common Stock, $0.0001 par value per share Sale -100% $1,850,000 $5.00 -370,000 0 13 Mar 2026 Pyu Pyu Capital LLC
Reuven Yeganeh PHGE Common Stock, $0.0001 par value per share Conversion of derivative security 370,000 370,000 13 Mar 2026 Pyu Pyu Capital LLC
Reuven Yeganeh PHGE Series Y Convertible Preferred Stock Conversion of derivative security -27.4% -740 1,960 13 Mar 2026 Pyu Pyu Capital LLC
Reuven Yeganeh PHGE Common Stock, $0.0001 par value per share Sale -100% $1,500,000 $5.00 -300,000 0 12 Mar 2026 Pyu Pyu Capital LLC
Reuven Yeganeh PHGE Series Y Convertible Preferred Stock Conversion of derivative security -18.2% -600 2,700 12 Mar 2026 Pyu Pyu Capital LLC
Reuven Yeganeh PHGE Common Stock, $0.0001 par value per share Conversion of derivative security 300,000 30,000 11 Mar 2026 Pyu Pyu Capital LLC
James E. Flynn PHGE Warrants Award 1,611,864 1,611,864 21 Apr 2025 Through Deerfield Healthcare Innovations Fund II, L.P.
James E. Flynn PHGE Warrants Award 1,611,864 1,611,864 21 Apr 2025 Through Deerfield Private Design Fund V, L.P.
Gregory Louis Merril PHGE Common Stock Options - right to Buy Award 17,600 17,600 14 Apr 2025 Direct
Merav Bassan PHGE Common Stock Award 79,597 79,597 14 Apr 2025 Direct
Merav Bassan PHGE Common Stock Options - right to Buy Award 95,000 95,000 14 Apr 2025 Direct
Jonathan Eitan Solomon PHGE Common Stock Award 126,748 126,748 14 Apr 2025 Direct
Jonathan Eitan Solomon PHGE Common Stock Options - right to Buy Award 380,500 380,500 14 Apr 2025 Direct
Jesse Goodman PHGE Common Stock Options - right to Buy Award 17,600 17,600 14 Apr 2025 Direct
Eddie Williams PHGE Common Stock Options - right to Buy Award 17,600 17,600 14 Apr 2025 Direct
Alan Charles Moses PHGE Common Stock Options - right to Buy Award 17,600 17,600 14 Apr 2025 Direct
Jonathan S. Leff PHGE Common Stock Options - right to Buy Award 17,600 17,600 14 Apr 2025 Direct
Susan Blum PHGE Common Stock Options - right to Buy Award 17,600 17,600 14 Apr 2025 Direct
Russell Greig PHGE Common Stock Options - right to Buy Award 35,200 35,200 14 Apr 2025 Direct
Marina Wolfson PHGE Common Stock Award 68,545 68,545 14 Apr 2025 Direct
Marina Wolfson PHGE Common Stock Options - right to Buy Award 95,000 95,000 14 Apr 2025 Direct
James E. Flynn PHGE Stock Option (Right to Buy) Award 17,600 17,600 14 Apr 2025 Through Deerfield Management Company, L.P.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.